
General
FDA approves first buprenorphine implant for treatment of opioid dependence
May 27, 2016
|
The U.S. Food and Drug Administration today approved Probuphine, the first buprenorphine implant for the maintenance treatment of opioid dependence. Probuphine is designed to provide a constant, low-level
Read More